 |
Press releases
31 January 2006
CMP Therapeutics Ltd (CMPT) announces completion of Euro 4.5 million series A funding round to develop a treatment for respiratory allergies.
|
 |
Download PDF |
Scientific Papers
Intranasal application of chitin microparticles down-regulates symptoms of allergic hypersensitivity to Dermatophagoides pteronyssinus and Aspergillus fumigatus in murine models of allergy.
P. Strong, H.Clark, K.Reid. Clin Exp Allergy 2002; 32 : 1794n -1800
|
|
Download PDF |
Chitin microparticles (CMP): A useful adjuvant for inducing viral specific immunity when delivered intranasally with an HIV-DNA vaccine.
Kenji Hamajima, Yoshizumi Kojima, Kiyohiko Matsui, Yoshihiko Toda, Nao Jounai, Tomomi Ozaki, Ke-Qin Xin, Peter Strong, and Kenji Okuda. Viral Immunology 2003; 16, 541 - 547
|
|
Download PDF |
Protection against influenza virus infection by intranasal administration of hemagglutinin vaccine with chitin microparticles as an adjuvant.
Hideki Hasegawa, Takeshi Ichinohe, Peter Strong, Izumi Watanabe, Satoshi Ito, Shin-ichi Tamura, Hiehiro Takahashi, Hirofumi Sawa, Joe Chiba, Takeshi Kurata, Tetsutaro Sata. J. Medical Virology, 2005; 75, 130 - 136
|
|
Download PDF |
Treatment with chitin microparticles is protective against lung histopathology in a murine asthma model.
C. Ozdemir, D. Yazi, M. Aydogan, T. Akkoc, N. N. Bahceciler, P. Strong , and I. B. Barlan
|
|
Download PDF |
Prophylactic Effects of Chitin Microparticles on Highly Pathogenic H5N1 Influenza Virus
Takeshi Ichinohe, Noriyo Nagata, Peter Strong, Shin-ichi Tamura, Hidehiro Takahashi, Ai Ninomiya, Masaki Imai, Takato Odagiri, Masato Tashiro, Hirofumi Sawa, Joe Chiba, Takeshi Kurata, Tetsutaro Sata, and Hideki Hasegawa
|
|
Download PDF |
|
|
|
|
|
